Celcuity Inc.

Celcuity Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Celcuity Inc. is a mediocre stock to choose.

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commerci...

News

Can Celcuity (CELC) Climb 87.59% to Reach the Level Wall Street Analysts Expect?

Zacks Investment Research Celcuity, Inc. (CELC) closed the last trading session at $15.23, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall...\n more…

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Simply Wall St Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...\n more…

Celcuity files $400M mixed securities shelf

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Zicix (OTCMKTS:ZICX) versus Celcuity (NASDAQ:CELC) Financial Review

Ticker Report Zicix (OTCMKTS:ZICX - Get Free Report) and Celcuity (NASDAQ:CELC - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on...\n more…

Lifesci Capital Initiates Coverage on Celcuity (NASDAQ:CELC)

Ticker Report Lifesci Capital started coverage on shares of Celcuity (NASDAQ:CELC - Free Report) in a report issued on Monday morning, Benzinga reports. The brokerage issued an outperform rating and a $27.00...\n more…